Limits...
Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I.

Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VL - An Bras Dermatol (2014 Mar-Apr)

Bottom Line: Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus.The clinical manifestations are variable and depend on the interaction of several factors including the site of infection and the host's immunity.This article revises the current knowledge about this disease's physiopathology and immunology as well as detailing the possible clinical presentations.

View Article: PubMed Central - PubMed

Affiliation: Pernambuco Federal University, Recife, PE, Brazil.

ABSTRACT
Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus. The clinical manifestations are variable and depend on the interaction of several factors including the site of infection and the host's immunity. This article revises the current knowledge about this disease's physiopathology and immunology as well as detailing the possible clinical presentations.

Show MeSH

Related in: MedlinePlus

Scrofuloderma
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4008050&req=5

f03: Scrofuloderma

Mentions: It reaches the skin from adjacent structures where infection has developed, such aslymph nodes, bones, joints or testicles (Figures 3and 4).22,26 The main sites arecervical lymph nodal chains. Besides these areas, coexistence with pulmonarytuberculosis is frequent.19 Theoccurrence of scrofuloderma after BCG vaccination has been rarely reported.30


Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I.

Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VL - An Bras Dermatol (2014 Mar-Apr)

Scrofuloderma
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4008050&req=5

f03: Scrofuloderma
Mentions: It reaches the skin from adjacent structures where infection has developed, such aslymph nodes, bones, joints or testicles (Figures 3and 4).22,26 The main sites arecervical lymph nodal chains. Besides these areas, coexistence with pulmonarytuberculosis is frequent.19 Theoccurrence of scrofuloderma after BCG vaccination has been rarely reported.30

Bottom Line: Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus.The clinical manifestations are variable and depend on the interaction of several factors including the site of infection and the host's immunity.This article revises the current knowledge about this disease's physiopathology and immunology as well as detailing the possible clinical presentations.

View Article: PubMed Central - PubMed

Affiliation: Pernambuco Federal University, Recife, PE, Brazil.

ABSTRACT
Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus. The clinical manifestations are variable and depend on the interaction of several factors including the site of infection and the host's immunity. This article revises the current knowledge about this disease's physiopathology and immunology as well as detailing the possible clinical presentations.

Show MeSH
Related in: MedlinePlus